rs759937836

Variant summary

Our verdict is Likely benign. The variant received -2 ACMG points: 0P and 2B. BP4_Moderate

The NM_213607.3(DNAAF19):​c.710A>G​(p.Glu237Gly) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000173 in 1,562,554 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 17/22 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★★). Synonymous variant affecting the same amino acid position (i.e. E237E) has been classified as Likely benign.

Frequency

Genomes: 𝑓 0.000033 ( 0 hom., cov: 32)
Exomes 𝑓: 0.000016 ( 0 hom. )

Consequence

DNAAF19
NM_213607.3 missense

Scores

19

Clinical Significance

Uncertain significance criteria provided, multiple submitters, no conflicts U:2

Conservation

PhyloP100: -0.264

Publications

1 publications found
Variant links:
Genes affected
DNAAF19 (HGNC:32700): (coiled-coil domain containing 103) Enables protein homodimerization activity. Involved in axonemal dynein complex assembly; cilium movement; and determination of left/right symmetry. Predicted to be located in axoneme. Predicted to be part of outer dynein arm. Implicated in primary ciliary dyskinesia 17. [provided by Alliance of Genome Resources, Apr 2022]
DNAAF19 Gene-Disease associations (from GenCC):
  • primary ciliary dyskinesia 17
    Inheritance: AR Classification: DEFINITIVE, STRONG, MODERATE Submitted by: ClinGen, Ambry Genetics, Labcorp Genetics (formerly Invitae), PanelApp Australia, G2P
  • primary ciliary dyskinesia
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Likely_benign. The variant received -2 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.08770427).

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
DNAAF19NM_213607.3 linkc.710A>G p.Glu237Gly missense_variant Exon 4 of 4 ENST00000417826.3 NP_998772.1 Q8IW40-1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
CCDC103ENST00000417826.3 linkc.710A>G p.Glu237Gly missense_variant Exon 4 of 4 1 NM_213607.3 ENSP00000391692.2 Q8IW40-1
CCDC103ENST00000410006.6 linkc.710A>G p.Glu237Gly missense_variant Exon 4 of 4 2 ENSP00000387252.1 Q8IW40-1
CCDC103ENST00000357776.6 linkc.710A>G p.Glu237Gly missense_variant, splice_region_variant Exon 4 of 4 2 ENSP00000350420.2 F8W6J8

Frequencies

GnomAD3 genomes
AF:
0.0000329
AC:
5
AN:
151806
Hom.:
0
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.0000484
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.0000442
Gnomad OTH
AF:
0.00
GnomAD2 exomes
AF:
0.00
AC:
0
AN:
169316
AF XY:
0.00
Gnomad AFR exome
AF:
0.00
Gnomad AMR exome
AF:
0.00
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.00
Gnomad OTH exome
AF:
0.00
GnomAD4 exome
AF:
0.0000156
AC:
22
AN:
1410748
Hom.:
0
Cov.:
32
AF XY:
0.0000186
AC XY:
13
AN XY:
697204
show subpopulations
African (AFR)
AF:
0.00
AC:
0
AN:
32228
American (AMR)
AF:
0.00
AC:
0
AN:
36696
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
25164
East Asian (EAS)
AF:
0.00
AC:
0
AN:
36774
South Asian (SAS)
AF:
0.00
AC:
0
AN:
81098
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
49608
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
5432
European-Non Finnish (NFE)
AF:
0.0000203
AC:
22
AN:
1085358
Other (OTH)
AF:
0.00
AC:
0
AN:
58390
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.527
Heterozygous variant carriers
0
2
3
5
6
8
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.0000329
AC:
5
AN:
151806
Hom.:
0
Cov.:
32
AF XY:
0.0000135
AC XY:
1
AN XY:
74140
show subpopulations
African (AFR)
AF:
0.0000484
AC:
2
AN:
41284
American (AMR)
AF:
0.00
AC:
0
AN:
15256
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
3470
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5180
South Asian (SAS)
AF:
0.00
AC:
0
AN:
4796
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
10568
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
316
European-Non Finnish (NFE)
AF:
0.0000442
AC:
3
AN:
67940
Other (OTH)
AF:
0.00
AC:
0
AN:
2088
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.525
Heterozygous variant carriers
0
0
1
1
2
2
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.0000341
Hom.:
0
Bravo
AF:
0.0000264

ClinVar

Significance: Uncertain significance
Submissions summary: Uncertain:2
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

Primary ciliary dyskinesia Uncertain:2
Aug 27, 2021
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This sequence change replaces glutamic acid with glycine at codon 237 of the CCDC103 protein (p.Glu237Gly). The glutamic acid residue is weakly conserved and there is a moderate physicochemical difference between glutamic acid and glycine. This variant is not present in population databases (ExAC no frequency). This variant has not been reported in the literature in individuals affected with CCDC103-related conditions. ClinVar contains an entry for this variant (Variation ID: 455030). Algorithms developed to predict the effect of missense changes on protein structure and function output the following: SIFT: "Tolerated"; PolyPhen-2: "Not Available"; Align-GVGD: "Class C0". The glycine amino acid residue is found in multiple mammalian species, which suggests that this missense change does not adversely affect protein function. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. -

Nov 08, 2018
UNC Molecular Genetics Laboratory, University of North Carolina at Chapel Hill
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.044
BayesDel_addAF
Benign
-0.092
T
BayesDel_noAF
Benign
-0.37
CADD
Benign
0.76
DANN
Benign
0.78
DEOGEN2
Benign
0.033
T;.;T;.
Eigen
Benign
-1.6
Eigen_PC
Benign
-1.6
FATHMM_MKL
Benign
0.0044
N
LIST_S2
Benign
0.26
.;T;.;T
M_CAP
Benign
0.050
D
MetaRNN
Benign
0.053
T;T;T;T
MetaSVM
Benign
-0.90
T
MutationAssessor
Benign
-1.4
N;.;N;.
PhyloP100
-0.26
PrimateAI
Benign
0.24
T
PROVEAN
Benign
-0.010
N;N;N;.
REVEL
Benign
0.23
Sift
Benign
0.32
T;D;T;.
Sift4G
Benign
0.31
T;T;T;T
Polyphen
0.0
B;.;B;.
Vest4
0.030
MVP
0.40
MPC
0.22
ClinPred
0.24
T
GERP RS
-6.8
Varity_R
0.027
gMVP
0.40
Mutation Taster
=97/3
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs759937836; hg19: chr17-42980166; API